# Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load

> **NCT06974877** · PHASE1 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 30 (estimated)

## Conditions studied

- Cryopyrin-Associated Periodic Syndromes
- Amyloidosis

## Interventions

- **DRUG:** 124I AT-01

## Key facts

- **NCT ID:** NCT06974877
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-10
- **Primary completion:** 2031-07-01
- **Final completion:** 2032-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06974877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06974877, "Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06974877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*